{
    "Id": "0E-0B-AC-4E-02-58-B7-BE-F0-DA-02-EB-92-50-2B-8F-45-05-53-AB-3A-27-0E-CD-B3-10-71-67-59-81-E4-A3",
    "ContentSourceId": "03e85e81-f3bb-4c2c-944d-b6722870407b",
    "Title": "739: AI is Eating Biology and Chemistry, with Dr. Ingmar Schuster",
    "SourceUrl": "https://www.podtrac.com/pts/redirect.mp3/chrt.fm/track/E581B9/arttrk.com/p/VI4CS/pscrb.fm/rss/p/traffic.megaphone.fm/SUPERDATASCIENCEPTYLTD7857327550.mp3?updated=1716818988",
    "Description": "\n        <p>AI Protein design, machine learning and cancer care, and pharmaceuticals: At Exazyme, CEO and Co-Founder Ingmar Schuster uses AI to design proteins. He speaks with Jon Krohn about their wider applications in pharmaceuticals and chemistry, how Kernel methods make the design of synthetic biological catalysts more efficient, and when to use shallow machine learning over deep learning.<br><br>This episode is brought to you by <a href=\"https://gurobi.com/sds\">Gurobi</a>, the Decision Intelligence Leader. Interested in sponsoring a SuperDataScience Podcast episode? Visit <a href=\"https://jonkrohn.com/podcast\">JonKrohn.com/podcast</a> for sponsorship information.<br><br>In this episode you will learn:<br>\u2022 On designing proteins with AI [03:14]<br>\u2022 Designing proteins at Exazyme [08:22]<br>\u2022 About the kernel methods [18:10]<br>\u2022 The importance of human-led approaches in protein research [35:44]<br>\u2022 Europe\u2019s focus on AI regulation [43:45]<br>\u2022 Deep vs shallow in AI [59:35]<br>\u2022 How a background in academia helps with entrepreneurship [1:09:17]<br><br>Additional materials: <a href=\"https://www.superdatascience.com/739\">www.superdatascience.com/739</a></p>\n      ",
    "EnclosureUrl": "https://www.podtrac.com/pts/redirect.mp3/chrt.fm/track/E581B9/arttrk.com/p/VI4CS/pscrb.fm/rss/p/traffic.megaphone.fm/SUPERDATASCIENCEPTYLTD7857327550.mp3?updated=1716818988"
}